Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet and behaviours, and executive chair and former CEO Saeju Jeong said the move into providing semaglutide is "in line with our mission to help everyone everywhere live better longer." The company is offering compounded semaglutide for $149 for the first month and $279 for subsequent months, pairing the supply of the drug to its digital health platform to create a system that can achieve "sustainable, long-term weight loss" and help people eventually taper off treatment whilst keeping the weight off, said Jeong in a LinkedIn post
Retatrutide Research Peptide Retatrutide Research Peptide is available in 5mg, 10mg, and 20mg strengths from Dakota Peptology
Get In Touch Why Researchers Choose Retatrutide Retatrutide is gaining attention for its multi-receptor activity in metabolic research, targeting GLP-1, GIP, and glucagon pathways with strong study potential
Glucagon-like peptide-1 or GLP-1 is native to the body and is released from the small intestine after a meal ingestion
GLP-1 medications are effective in helping people lose weight and manage blood sugar levels
These drugs could have impacts on development
US$ 25.66
US$ 27.30
US$ 23.12
-min.png)
